Polyarteritis nodosa (PAN) is a rare vasculitis affecting medium-sized vessels. Cutaneous PAN is a clinical variant, and we report the first case of empagliflozin-induced cutaneous PAN in a 69-year-old man. After starting empagliflozin, the patient presented with tender subcutaneous nodules on his legs, which showed a medium-sized vessel vasculitis on histopathology. Upon cessation of this medication, he had full resolution of these nodules. This case illustrates that empagliflozin can induce cutaneous PAN, and further attention to this medication’s association with cutaneous PAN is warranted.
JennetteJCFalkRJBaconPA, et al.et al2012 revised Inter-national Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11.
2.
CulverBItkinAPischelK.Case report and review of minocycline-induced cutaneous polyarteritis nodosa. Arthritis Rheum. 2005;53(3):468-470.
3.
AbadSKambouchnerMNejjariMDhoteR.Additional case of minocycline-induced cutaneous polyarteritis nodosa: comment on the article by Culver et al. Arthritis Rheum. 2006;55(5):831; author reply 832.
4.
Contreras-SteylsMLópez-NavarroNGallegoEMoyanoBEstradaDHerreraE.Gemcitabine therapy-associated cutaneous vasculitis with a polyarteritis nodosa-like pattern. Int J Dermatol. 2013;52(8):1029-1031.
5.
VenturaFAntunesHBritoCPardalFPereiraTVieiraAP. Cutaneous polyarteritis nodosa in a child following hepatitis B vaccination. Eur J Dermatol. 19(4):400-401.
6.
DaoudMSHuttonKPGibsonLE.Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br J Dermatol. 1997;136(5):706-713.
7.
ElkayamOLevartovskyDBrautbarCet al. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am J Med. 1998;105(6):484-487.
KawakamiTYamazakiMMizoguchiMSomaY.High titer of anti–phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa. Arthritis Rheum. 2007;57(8):1507-1513.
10.
ClarCGillJACourtRWaughN. Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes. BMJ Open. 2012;2(5).
11.
MorganAJSchwartzRA.Cutaneous polyarteritis nodosa: a comprehensive review. Int J Dermatol. 2010;49(7):750-756.
12.
PagnouxCSerorRHenegarCet al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum. 2010;62(2):616-626.
